Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong
· Delayed Price · Currency is HKD 64.90
+3.95 (6.48%)
Mar 10, 2026, 1:15 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 12.12 billion as of March 9, 2026.
Market Cap
12.12B
Enterprise Value
11.96B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
64.90
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 12.12B, a decrease of -6.57%. That is a compound annual growth rate of -10.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.71B | 5.59% |
| Dec 31, 2025 | 10.14B | -21.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 11.05B |
| HBM Holdings | 10.08B |
| Shanghai Haohai Biological Technology | 9.96B |
| CStone Pharmaceuticals | 9.79B |
| Everest Medicines | 12.98B |
| Abbisko Cayman | 7.99B |
| Lepu Biopharma | 7.92B |
| Alphamab Oncology | 7.60B |